Sonnet BioTherapeutics Holdings, Inc. Gains 41.24%

Fri 31 Jul 20 at 05:36 PM
Sonnet BioTherapeutics Holdings, Inc. Gains 41.24%

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) shot up at $4.11, representing a gain of 41.2%. On Thu 30 Jul 20, SONN:NASDAQ touched a New 2-Week Intraday Low of $2.52. The stock appeared on our News Catalysts scanner on Mon 20 Jul 20 at 11:24 AM in the 'BIOTECH' category. From Thu 16 Jul 20, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Mon 20 Jul 20 at $4.04 with a volume of 2M+, and its share price has been moving sideways in recent weeks.

About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.